

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 7.93222060 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 6.76578404 |
| 3 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.29022146 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.74183062 |
| 5 | regulation of platelet activation (GO:0010543) | 4.65234340 |
| 6 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.38970282 |
| 7 | negative regulation of heart rate (GO:0010459) | 4.32200434 |
| 8 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.29578704 |
| 9 | regulation of platelet aggregation (GO:0090330) | 4.27716440 |
| 10 | negative regulation of protein localization to cell surface (GO:2000009) | 4.26410728 |
| 11 | platelet dense granule organization (GO:0060155) | 4.26360928 |
| 12 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.16221878 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.15857182 |
| 14 | blood coagulation, intrinsic pathway (GO:0007597) | 4.08131670 |
| 15 | endothelium development (GO:0003158) | 4.02401333 |
| 16 | negative regulation of platelet activation (GO:0010544) | 3.96722677 |
| 17 | angiogenesis involved in wound healing (GO:0060055) | 3.90566016 |
| 18 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.78067290 |
| 19 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.76461748 |
| 20 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.70494158 |
| 21 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.70494158 |
| 22 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.66206441 |
| 23 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.59633342 |
| 24 | negative regulation of response to food (GO:0032096) | 3.58375985 |
| 25 | negative regulation of appetite (GO:0032099) | 3.58375985 |
| 26 | platelet aggregation (GO:0070527) | 3.56755989 |
| 27 | negative regulation of norepinephrine secretion (GO:0010700) | 3.53407390 |
| 28 | amine catabolic process (GO:0009310) | 3.49260220 |
| 29 | cellular biogenic amine catabolic process (GO:0042402) | 3.49260220 |
| 30 | low-density lipoprotein particle remodeling (GO:0034374) | 3.43058451 |
| 31 | regulation of lipoprotein metabolic process (GO:0050746) | 3.38406155 |
| 32 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.37168269 |
| 33 | phospholipid homeostasis (GO:0055091) | 3.33497694 |
| 34 | adenosine receptor signaling pathway (GO:0001973) | 3.31969544 |
| 35 | dopamine transport (GO:0015872) | 3.29215237 |
| 36 | regulation of memory T cell differentiation (GO:0043380) | 3.28574233 |
| 37 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.26167740 |
| 38 | purinergic receptor signaling pathway (GO:0035587) | 3.22290983 |
| 39 | neutrophil activation (GO:0042119) | 3.20675290 |
| 40 | positive regulation of mast cell activation (GO:0033005) | 3.18640539 |
| 41 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.17842217 |
| 42 | lipoxygenase pathway (GO:0019372) | 3.17612405 |
| 43 | regulation of integrin activation (GO:0033623) | 3.16055191 |
| 44 | adenosine metabolic process (GO:0046085) | 3.09642384 |
| 45 | sequestering of actin monomers (GO:0042989) | 3.07866278 |
| 46 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.07683412 |
| 47 | regulation of endothelial cell differentiation (GO:0045601) | 3.05908838 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.01777296 |
| 49 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.00550550 |
| 50 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.00127738 |
| 51 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.98410163 |
| 52 | regulation of female receptivity (GO:0045924) | 2.97247049 |
| 53 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.94937562 |
| 54 | plasma membrane fusion (GO:0045026) | 2.94834986 |
| 55 | negative regulation of T cell apoptotic process (GO:0070233) | 2.94209042 |
| 56 | mitochondrial calcium ion transport (GO:0006851) | 2.93613279 |
| 57 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.92091054 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 2.91619339 |
| 59 | polyamine biosynthetic process (GO:0006596) | 2.88108268 |
| 60 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.85215410 |
| 61 | granulocyte activation (GO:0036230) | 2.84828947 |
| 62 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.84563152 |
| 63 | reverse cholesterol transport (GO:0043691) | 2.84028870 |
| 64 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.82644808 |
| 65 | regulation of sensory perception of pain (GO:0051930) | 2.79339570 |
| 66 | regulation of sensory perception (GO:0051931) | 2.79339570 |
| 67 | sulfation (GO:0051923) | 2.78290623 |
| 68 | regulation of regulatory T cell differentiation (GO:0045589) | 2.77235043 |
| 69 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.76002306 |
| 70 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.76002306 |
| 71 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.72481908 |
| 72 | positive regulation of macrophage differentiation (GO:0045651) | 2.71846281 |
| 73 | regulation of norepinephrine secretion (GO:0014061) | 2.70248109 |
| 74 | autophagic vacuole fusion (GO:0000046) | 2.69769678 |
| 75 | positive regulation of protein homodimerization activity (GO:0090073) | 2.68215417 |
| 76 | superoxide anion generation (GO:0042554) | 2.67246867 |
| 77 | platelet degranulation (GO:0002576) | 2.65472529 |
| 78 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.65357644 |
| 79 | parturition (GO:0007567) | 2.65246337 |
| 80 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.64312431 |
| 81 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.62121740 |
| 82 | rhodopsin mediated signaling pathway (GO:0016056) | 2.59985059 |
| 83 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.58446819 |
| 84 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.58335581 |
| 85 | negative regulation of cation channel activity (GO:2001258) | 2.56316903 |
| 86 | megakaryocyte development (GO:0035855) | 2.55578974 |
| 87 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.54636743 |
| 88 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.54112809 |
| 89 | female mating behavior (GO:0060180) | 2.53797040 |
| 90 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.53026753 |
| 91 | amine biosynthetic process (GO:0009309) | 2.51265014 |
| 92 | multicellular organism reproduction (GO:0032504) | 2.50534889 |
| 93 | DNA deamination (GO:0045006) | 2.49681031 |
| 94 | regulation of thymocyte apoptotic process (GO:0070243) | 2.47155442 |
| 95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46915573 |
| 96 | monoamine transport (GO:0015844) | 2.46856822 |
| 97 | negative regulation of heart contraction (GO:0045822) | 2.46466407 |
| 98 | nitric oxide mediated signal transduction (GO:0007263) | 2.46064748 |
| 99 | positive regulation of hemostasis (GO:1900048) | 2.45805950 |
| 100 | positive regulation of blood coagulation (GO:0030194) | 2.45805950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.29610447 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.27933923 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.96429440 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.90212299 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.64516532 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.58453494 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.52294226 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.33194071 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.21815257 |
| 10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.08796688 |
| 11 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.04855482 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02969516 |
| 13 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.00563249 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.94383190 |
| 15 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.89267240 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.85635325 |
| 17 | EWS_26573619_Chip-Seq_HEK293_Human | 1.83430262 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82978607 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.82812664 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81977979 |
| 21 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79743061 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71183770 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70943396 |
| 24 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.70642937 |
| 25 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.66842175 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.66577126 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64397834 |
| 28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.62360529 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60775344 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58250187 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57991999 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.55828933 |
| 33 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53443497 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53443497 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49474535 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47574131 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47300018 |
| 38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47133372 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45044633 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44957906 |
| 41 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.44229577 |
| 42 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.44229577 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43820215 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41612320 |
| 45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40711560 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40020940 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39097863 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37089101 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37085636 |
| 50 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31308268 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30655387 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30073244 |
| 53 | GATA2_19941826_ChIP-Seq_K562_Human | 1.29993349 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27774669 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27070720 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23889838 |
| 57 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22644509 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21949146 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21090244 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20960593 |
| 61 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.19852120 |
| 62 | AR_20517297_ChIP-Seq_VCAP_Human | 1.19011844 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18830095 |
| 64 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18824978 |
| 65 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18650278 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18572895 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18220433 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18018173 |
| 69 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17465570 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15817378 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.14097237 |
| 72 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12229942 |
| 73 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12078561 |
| 74 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12078561 |
| 75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10016219 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09901839 |
| 77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09731762 |
| 78 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09421375 |
| 79 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09056680 |
| 80 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08700494 |
| 81 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.08684078 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07840369 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07401918 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05232970 |
| 85 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.03791639 |
| 86 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03370793 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01580691 |
| 88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01275413 |
| 89 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01191752 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97736219 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97620351 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97620351 |
| 93 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.96928255 |
| 94 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96821745 |
| 95 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95945411 |
| 96 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95906368 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95737258 |
| 98 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95495997 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95244561 |
| 100 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.94660686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 7.26164399 |
| 2 | MP0008004_abnormal_stomach_pH | 4.43538220 |
| 3 | MP0005084_abnormal_gallbladder_morpholo | 3.05947504 |
| 4 | MP0003724_increased_susceptibility_to | 3.02489320 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 2.94457885 |
| 6 | MP0005646_abnormal_pituitary_gland | 2.42108793 |
| 7 | MP0000230_abnormal_systemic_arterial | 2.32452499 |
| 8 | MP0002736_abnormal_nociception_after | 2.29011891 |
| 9 | MP0005167_abnormal_blood-brain_barrier | 2.26953939 |
| 10 | MP0008872_abnormal_physiological_respon | 2.26049821 |
| 11 | MP0001879_abnormal_lymphatic_vessel | 2.23622636 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.19696660 |
| 13 | MP0005083_abnormal_biliary_tract | 2.04789179 |
| 14 | MP0003011_delayed_dark_adaptation | 2.01985083 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.01595443 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 1.95308141 |
| 17 | MP0005410_abnormal_fertilization | 1.95224229 |
| 18 | MP0000343_altered_response_to | 1.94003677 |
| 19 | MP0008775_abnormal_heart_ventricle | 1.88807767 |
| 20 | MP0002102_abnormal_ear_morphology | 1.85841022 |
| 21 | MP0000372_irregular_coat_pigmentation | 1.84864738 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.78257466 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.76342922 |
| 24 | MP0006054_spinal_hemorrhage | 1.72154911 |
| 25 | MP0005671_abnormal_response_to | 1.69454593 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.67507025 |
| 27 | MP0003828_pulmonary_edema | 1.64535753 |
| 28 | MP0009764_decreased_sensitivity_to | 1.50595624 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.48933824 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.43556075 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.43406438 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.43406438 |
| 33 | MP0003638_abnormal_response/metabolism_ | 1.40372457 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.39291839 |
| 35 | MP0003718_maternal_effect | 1.37069089 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.36205212 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.36122466 |
| 38 | MP0004510_myositis | 1.35518627 |
| 39 | MP0004484_altered_response_of | 1.25390400 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.22746790 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19016155 |
| 42 | MP0009697_abnormal_copulation | 1.18189374 |
| 43 | MP0004147_increased_porphyrin_level | 1.17633786 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.13397130 |
| 45 | MP0009765_abnormal_xenobiotic_induced | 1.10062066 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.08762801 |
| 47 | MP0000249_abnormal_blood_vessel | 1.06291109 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.05431599 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.05109244 |
| 50 | MP0001905_abnormal_dopamine_level | 1.05027579 |
| 51 | MP0001663_abnormal_digestive_system | 1.04574572 |
| 52 | MP0009763_increased_sensitivity_to | 1.03405748 |
| 53 | MP0004142_abnormal_muscle_tone | 1.02165108 |
| 54 | MP0003186_abnormal_redox_activity | 1.02087715 |
| 55 | MP0005253_abnormal_eye_physiology | 0.97054989 |
| 56 | MP0002876_abnormal_thyroid_physiology | 0.96016380 |
| 57 | MP0001756_abnormal_urination | 0.95423107 |
| 58 | MP0010329_abnormal_lipoprotein_level | 0.94786315 |
| 59 | MP0001970_abnormal_pain_threshold | 0.93523903 |
| 60 | MP0004130_abnormal_muscle_cell | 0.92610195 |
| 61 | MP0005365_abnormal_bile_salt | 0.92463405 |
| 62 | MP0002723_abnormal_immune_serum | 0.90166622 |
| 63 | MP0005174_abnormal_tail_pigmentation | 0.88024521 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 0.87819371 |
| 65 | MP0005165_increased_susceptibility_to | 0.86549875 |
| 66 | MP0003879_abnormal_hair_cell | 0.86011282 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.85349276 |
| 68 | MP0005647_abnormal_sex_gland | 0.84997076 |
| 69 | MP0002735_abnormal_chemical_nociception | 0.84717933 |
| 70 | MP0002452_abnormal_antigen_presenting | 0.83237933 |
| 71 | MP0002398_abnormal_bone_marrow | 0.80401968 |
| 72 | MP0000685_abnormal_immune_system | 0.80258421 |
| 73 | MP0003195_calcinosis | 0.79152434 |
| 74 | MP0009046_muscle_twitch | 0.79041335 |
| 75 | MP0002972_abnormal_cardiac_muscle | 0.78507245 |
| 76 | MP0002132_abnormal_respiratory_system | 0.77518519 |
| 77 | MP0005595_abnormal_vascular_smooth | 0.77076973 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.76698678 |
| 79 | MP0000383_abnormal_hair_follicle | 0.76209401 |
| 80 | MP0000689_abnormal_spleen_morphology | 0.76160597 |
| 81 | MP0001800_abnormal_humoral_immune | 0.75678405 |
| 82 | MP0005385_cardiovascular_system_phenoty | 0.74309253 |
| 83 | MP0001544_abnormal_cardiovascular_syste | 0.74309253 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.73786708 |
| 85 | MP0005085_abnormal_gallbladder_physiolo | 0.73725335 |
| 86 | MP0003303_peritoneal_inflammation | 0.73470048 |
| 87 | MP0005620_abnormal_muscle_contractility | 0.73283532 |
| 88 | MP0004085_abnormal_heartbeat | 0.72439636 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.72416084 |
| 90 | MP0003136_yellow_coat_color | 0.71577981 |
| 91 | MP0001851_eye_inflammation | 0.71392461 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.71246423 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.71111882 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.70996022 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.70494292 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.68490552 |
| 97 | MP0005389_reproductive_system_phenotype | 0.67186380 |
| 98 | MP0005171_absent_coat_pigmentation | 0.65817185 |
| 99 | MP0005187_abnormal_penis_morphology | 0.65176348 |
| 100 | MP0002429_abnormal_blood_cell | 0.65070356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.62292428 |
| 2 | Menorrhagia (HP:0000132) | 7.53003134 |
| 3 | Petechiae (HP:0000967) | 7.22322694 |
| 4 | Increased mean platelet volume (HP:0011877) | 7.15849865 |
| 5 | Abnormal platelet volume (HP:0011876) | 6.53790064 |
| 6 | Purpura (HP:0000979) | 6.09484410 |
| 7 | Epistaxis (HP:0000421) | 5.64010151 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.69274913 |
| 9 | Gingival bleeding (HP:0000225) | 4.50666400 |
| 10 | Decreased central vision (HP:0007663) | 4.16211155 |
| 11 | Abnormal platelet function (HP:0011869) | 3.71373589 |
| 12 | Impaired platelet aggregation (HP:0003540) | 3.71373589 |
| 13 | Dyschromatopsia (HP:0007641) | 3.63231782 |
| 14 | Stomatitis (HP:0010280) | 3.45277864 |
| 15 | Thyroid-stimulating hormone excess (HP:0002925) | 3.41276050 |
| 16 | Abnormal pupillary function (HP:0007686) | 3.08638497 |
| 17 | Conjunctival telangiectasia (HP:0000524) | 2.95185372 |
| 18 | Poikilocytosis (HP:0004447) | 2.92435554 |
| 19 | Abolished electroretinogram (ERG) (HP:0000550) | 2.89019753 |
| 20 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.87869237 |
| 21 | Spontaneous hematomas (HP:0007420) | 2.82154051 |
| 22 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.81798371 |
| 23 | Paralysis (HP:0003470) | 2.80611637 |
| 24 | Abnormality of lateral ventricle (HP:0030047) | 2.77058292 |
| 25 | Pancreatic cysts (HP:0001737) | 2.63894963 |
| 26 | Renal cortical cysts (HP:0000803) | 2.60586790 |
| 27 | Congenital stationary night blindness (HP:0007642) | 2.51731749 |
| 28 | Generalized aminoaciduria (HP:0002909) | 2.50642467 |
| 29 | Acanthocytosis (HP:0001927) | 2.45943051 |
| 30 | Bruising susceptibility (HP:0000978) | 2.44348299 |
| 31 | Abnormality of alanine metabolism (HP:0010916) | 2.37440612 |
| 32 | Hyperalaninemia (HP:0003348) | 2.37440612 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.37440612 |
| 34 | Abnormality of the prostate (HP:0008775) | 2.36954167 |
| 35 | Abnormal auditory evoked potentials (HP:0006958) | 2.35212771 |
| 36 | Tinnitus (HP:0000360) | 2.34768245 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 2.34371271 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34053318 |
| 39 | Abnormal drinking behavior (HP:0030082) | 2.32195453 |
| 40 | Polydipsia (HP:0001959) | 2.32195453 |
| 41 | Congenital sensorineural hearing impairment (HP:0008527) | 2.25814028 |
| 42 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.25548222 |
| 43 | Joint swelling (HP:0001386) | 2.15571290 |
| 44 | Type 2 muscle fiber atrophy (HP:0003554) | 2.15553620 |
| 45 | Hypomagnesemia (HP:0002917) | 2.13783850 |
| 46 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.12751661 |
| 47 | Pancreatic fibrosis (HP:0100732) | 2.10838581 |
| 48 | Tongue fasciculations (HP:0001308) | 2.08776424 |
| 49 | Renal Fanconi syndrome (HP:0001994) | 2.06963281 |
| 50 | True hermaphroditism (HP:0010459) | 2.05678214 |
| 51 | Abnormal ciliary motility (HP:0012262) | 2.05656787 |
| 52 | Attenuation of retinal blood vessels (HP:0007843) | 2.05134662 |
| 53 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.02293885 |
| 54 | Increased density of long bones (HP:0006392) | 1.99799249 |
| 55 | Increased IgM level (HP:0003496) | 1.94415769 |
| 56 | Central scotoma (HP:0000603) | 1.94231922 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 1.92968241 |
| 58 | Hypothermia (HP:0002045) | 1.91340958 |
| 59 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.89624474 |
| 60 | Abnormality of iron homeostasis (HP:0011031) | 1.88877699 |
| 61 | Increased corneal curvature (HP:0100692) | 1.88860498 |
| 62 | Keratoconus (HP:0000563) | 1.88860498 |
| 63 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.88784117 |
| 64 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.88784117 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 1.86081799 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 1.86081799 |
| 67 | Nausea (HP:0002018) | 1.85064122 |
| 68 | Autoimmune hemolytic anemia (HP:0001890) | 1.84934501 |
| 69 | Hypoplastic iliac wings (HP:0002866) | 1.78879948 |
| 70 | Abnormality of the common coagulation pathway (HP:0010990) | 1.78638811 |
| 71 | Biliary tract neoplasm (HP:0100574) | 1.78143507 |
| 72 | Hypoplasia of the fovea (HP:0007750) | 1.77937122 |
| 73 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77937122 |
| 74 | Hepatosplenomegaly (HP:0001433) | 1.76434386 |
| 75 | Muscle fibrillation (HP:0010546) | 1.73184587 |
| 76 | Congenital, generalized hypertrichosis (HP:0004540) | 1.73101824 |
| 77 | Upper limb muscle weakness (HP:0003484) | 1.72334843 |
| 78 | Muscle fiber atrophy (HP:0100295) | 1.72163992 |
| 79 | Spontaneous abortion (HP:0005268) | 1.72064798 |
| 80 | Polyuria (HP:0000103) | 1.71482297 |
| 81 | Clumsiness (HP:0002312) | 1.70683784 |
| 82 | Disproportionate short-trunk short stature (HP:0003521) | 1.70622424 |
| 83 | Hypoproteinemia (HP:0003075) | 1.70449020 |
| 84 | Visual hallucinations (HP:0002367) | 1.67681303 |
| 85 | Episodic fever (HP:0001954) | 1.65772903 |
| 86 | Abnormality of the fovea (HP:0000493) | 1.64752220 |
| 87 | Exertional dyspnea (HP:0002875) | 1.63422801 |
| 88 | Abnormality of magnesium homeostasis (HP:0004921) | 1.63233159 |
| 89 | Eosinophilia (HP:0001880) | 1.61952026 |
| 90 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.61235691 |
| 91 | Absent/shortened dynein arms (HP:0200106) | 1.61235691 |
| 92 | Hypophosphatemic rickets (HP:0004912) | 1.60766922 |
| 93 | Dysautonomia (HP:0002459) | 1.60715943 |
| 94 | Male infertility (HP:0003251) | 1.60059972 |
| 95 | Ventricular fibrillation (HP:0001663) | 1.59249635 |
| 96 | Albinism (HP:0001022) | 1.59144237 |
| 97 | IgG deficiency (HP:0004315) | 1.58095927 |
| 98 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.54978829 |
| 99 | Fibular aplasia (HP:0002990) | 1.54669983 |
| 100 | Cerebral hemorrhage (HP:0001342) | 1.52821746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 3.84666786 |
| 2 | TAOK3 | 3.63814387 |
| 3 | FRK | 2.95835169 |
| 4 | MYLK | 2.85361008 |
| 5 | TEC | 2.59602298 |
| 6 | ADRBK2 | 2.54745118 |
| 7 | MAP4K2 | 2.53752448 |
| 8 | PIK3CG | 2.37931122 |
| 9 | NUAK1 | 2.19310756 |
| 10 | BMPR1B | 2.09154252 |
| 11 | PTK2B | 2.04221739 |
| 12 | TRIM28 | 1.89679236 |
| 13 | BMX | 1.88549937 |
| 14 | BTK | 1.85342716 |
| 15 | TIE1 | 1.70539239 |
| 16 | ZAK | 1.69073085 |
| 17 | MAPKAPK3 | 1.68764224 |
| 18 | EIF2AK1 | 1.66159288 |
| 19 | TXK | 1.65296020 |
| 20 | GRK5 | 1.63010502 |
| 21 | ACVR1B | 1.56300388 |
| 22 | SYK | 1.54130077 |
| 23 | PLK2 | 1.50327433 |
| 24 | TLK1 | 1.49887683 |
| 25 | IKBKB | 1.48617403 |
| 26 | CSF1R | 1.46472055 |
| 27 | BCKDK | 1.44120267 |
| 28 | INSRR | 1.39878891 |
| 29 | GRK1 | 1.35666362 |
| 30 | FER | 1.27241131 |
| 31 | BMPR2 | 1.23187584 |
| 32 | STK3 | 1.17476576 |
| 33 | PKN1 | 1.16049441 |
| 34 | EPHA3 | 1.16047445 |
| 35 | ADRBK1 | 1.12813839 |
| 36 | ZAP70 | 1.11432779 |
| 37 | DAPK2 | 1.06144065 |
| 38 | WNK4 | 1.05994611 |
| 39 | PIM2 | 1.05504713 |
| 40 | RIPK4 | 1.05046502 |
| 41 | ILK | 1.04046563 |
| 42 | FES | 1.03973571 |
| 43 | PINK1 | 1.00898235 |
| 44 | MAPK13 | 0.97904568 |
| 45 | STK39 | 0.93414131 |
| 46 | ITK | 0.92757887 |
| 47 | KDR | 0.86959829 |
| 48 | IRAK1 | 0.86428767 |
| 49 | HCK | 0.81899008 |
| 50 | LYN | 0.80147010 |
| 51 | DAPK3 | 0.79213195 |
| 52 | TNK2 | 0.78863213 |
| 53 | GRK7 | 0.77557036 |
| 54 | MAP3K5 | 0.74954928 |
| 55 | CSNK1G3 | 0.74127354 |
| 56 | PRKCE | 0.73794197 |
| 57 | EPHB2 | 0.73448550 |
| 58 | BRSK2 | 0.72482973 |
| 59 | BCR | 0.70700224 |
| 60 | CSNK1G1 | 0.70243728 |
| 61 | ERBB2 | 0.69209753 |
| 62 | TNIK | 0.69003705 |
| 63 | PRKCQ | 0.68457426 |
| 64 | FLT3 | 0.66571615 |
| 65 | FGR | 0.65296702 |
| 66 | PAK3 | 0.64817936 |
| 67 | MAP3K12 | 0.64465395 |
| 68 | MATK | 0.64073707 |
| 69 | GRK6 | 0.63614708 |
| 70 | MARK3 | 0.62444976 |
| 71 | ABL2 | 0.61060444 |
| 72 | DAPK1 | 0.60961507 |
| 73 | CSNK1G2 | 0.59551505 |
| 74 | NLK | 0.56952940 |
| 75 | IGF1R | 0.56502089 |
| 76 | BLK | 0.56475708 |
| 77 | PRKD1 | 0.56358732 |
| 78 | VRK1 | 0.54751057 |
| 79 | PAK1 | 0.54443607 |
| 80 | SIK3 | 0.53915158 |
| 81 | MUSK | 0.52670820 |
| 82 | KIT | 0.52663222 |
| 83 | WNK3 | 0.51769964 |
| 84 | DYRK2 | 0.50376964 |
| 85 | STK38L | 0.49968207 |
| 86 | MINK1 | 0.49268362 |
| 87 | MAP2K7 | 0.49008332 |
| 88 | OXSR1 | 0.48728850 |
| 89 | CAMKK2 | 0.47598223 |
| 90 | PIK3CA | 0.46498760 |
| 91 | CAMK2A | 0.46076167 |
| 92 | RPS6KA5 | 0.45820955 |
| 93 | TGFBR1 | 0.42920325 |
| 94 | OBSCN | 0.42633892 |
| 95 | PHKG1 | 0.40392101 |
| 96 | PHKG2 | 0.40392101 |
| 97 | ERBB3 | 0.39696040 |
| 98 | LCK | 0.38812807 |
| 99 | PRKCA | 0.38773170 |
| 100 | ABL1 | 0.38672332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 3.85453957 |
| 2 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.97956732 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.80428504 |
| 4 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.60905638 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.32376344 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.28001442 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.19812793 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.13751533 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.07378999 |
| 10 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.05387660 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.05202792 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.88163196 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.83834632 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.81893470 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80997312 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68916582 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63724808 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.60248690 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.56633679 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.55289550 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.52386578 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50899676 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47842465 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46509305 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45482285 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43449844 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32283411 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31515876 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.31335256 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29926607 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27161009 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.26458642 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26302170 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24956975 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22075204 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15170345 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07558260 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06009708 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04528177 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03575692 |
| 41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.98327487 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 0.98314326 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98102627 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.94295813 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93920800 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93155044 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90304002 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89412491 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.88890321 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.88622223 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 0.84848716 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82957487 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 0.82572622 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79834890 |
| 55 | Mismatch repair_Homo sapiens_hsa03430 | 0.79189776 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79019466 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76212034 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75551488 |
| 59 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74446418 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.73971230 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69516296 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68179263 |
| 63 | Purine metabolism_Homo sapiens_hsa00230 | 0.67644243 |
| 64 | Alcoholism_Homo sapiens_hsa05034 | 0.63992033 |
| 65 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61442060 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59164473 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.59161782 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.59059851 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.58677196 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.57432718 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57008386 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.55641380 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55616964 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55285452 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.52829062 |
| 76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51817245 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.50913191 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50788267 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49749602 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.49551198 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49364966 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.49357244 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49135587 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48365413 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48360533 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48278676 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.48081416 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47466859 |
| 89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46830721 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46828389 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44589670 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43399247 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38462978 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.38409197 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38165116 |
| 96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37998833 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37604373 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.36203665 |
| 99 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36089054 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.35614865 |

